Abstract

MicroRNAs (miRNAs) are small RNA molecules that modulate gene and protein expression in hematopoiesis. Platelets are known to contain a fully functional miRNA machinery. While platelets used for transfusion are normally stored at room temperature, recent evidence suggests more favorable effects under a cold-storage condition, including higher adhesion and aggregation properties. Thus, we sought to determine whether functional differences in platelets are associated with the differential profiling of platelet miRNA expressions. To obtain the miRNA expression profile, next-generation sequencing was performed on human platelets obtained from 10 healthy subjects. The miRNAs were quantified after being stored in three different conditions: 1) baseline (before storage), 2) stored at 22°C with agitation for 72 h, and 3) stored at 4°C for 72 h. Following the identification of miRNAs by sequencing, the results were validated at the level of mature miRNAs from 18 healthy subjects, by using quantitative polymerase chain reaction (qPCR). Differential expression was observed for 125 miRNAs that were stored at 4°C and 9 miRNAs stored at 22°C as compared to the baseline. The validation study by qPCR confirmed that storage at 4°C increased the expression levels (fold change 95% CI) of mir-20a-5p (1.87, p<0.0001), mir-10a-3p (1.88, p<0.0001), mir-16-2-3p (1.54, p<0.01), and mir-223-5p (1.38, p<0.05), compared with those of the samples stored at 22°C. These results show that miRNAs correlate with platelet quality under specific storage conditions. The data indicate that miRNAs could be potentially used as biomarkers of platelet quality.

Highlights

  • Platelet transfusion is an essential medical treatment for patients with quantitative and qualitative disorders of platelets [1]

  • Nine miRNAs were identified as differentially expressed between baseline (Day 0) and room temperature storage (Day 3 room), and 68 miRNAs were identified between room temperature (Day 3 room) and cold (Day 3 cold) storage conditions (S1 and S2 Figs)

  • The miRNAs are arranged in ascending order of the False discovery rate-corrected P-values (FDR-P)-value (Day 0 vs. Day 3 cold)

Read more

Summary

Introduction

Platelet transfusion is an essential medical treatment for patients with quantitative and qualitative disorders of platelets [1]. Cold-storage conditions have been reported to promote favorable effects on hemostatic function [8, 9] Under such conditions, platelets are activated with greater P-selectin secretion and Glycoprotein Ib surface expression along with an increase in thromboxane A2 production [10,11,12]. Platelets are activated with greater P-selectin secretion and Glycoprotein Ib surface expression along with an increase in thromboxane A2 production [10,11,12] These functional enhancements in platelets by cold temperature lead to reduced bleeding time [8, 13], thereby being advantageous for patients with hemorrhage. It has been reported that the miRNA profile of platelets is related to cellular damage under room-temperature storage conditions [18]. We performed comprehensive analyses of miRNAs in normal human platelets using next-generation sequencing

Materials and methods
Results miRNA sequencing
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call